SPARC and chronic myelogenous leukemia, BCR-ABL1 positive: In the analyzed cell subsets there was a similar distribution of SPARC expression for HC and treated patients groups while in CML patients at diagnosis an increase of granulocytes expressing SPARC was observed at the expense of monocytes.